BREAKING: Healthcare regulator approves GlaxoSmithKline drug for severely ill Covid patients in UK

The monoclonal antibody Xevudy (sotrovimab), made by GlaxoSmithKline (GSK), has been approved for people in the UK at high risk of developing severe Covid-19, the Medicines and Healthcare products Regulatory Agency (MHRA) said. More to follow.